I agree Russell. That's what matters...a deal. Hopefully a good deal.
Right now, I would far rather a reasonable deal is locked away and we end up with a sub optimal board / management team than I would no crux deal but a better board / management team.
The clock is ticking heavily on Crux but the board and management can be fixed at any time / later if need be.
I sincerely hope this significant distraction does not scuttle things and torpedo the real prize here. Without a doubt this matter has become personal on both sides of the debate and neither party would appear to be completely squeaky clean in the tit for tat points scoring that seems to be taking place.
Russell, when you say "starting to hear about the structure of a deal and are now getting down to the wire."...what do you mean by that and where did you hear it?
- Forums
- ASX - By Stock
- shareholders will nix cottee comeback: nexus
I agree Russell. That's what matters...a deal. Hopefully a good...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $70.11M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.3¢ | $3.257K | 13.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6601 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 145820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6601 | 0.240 |
3 | 17501 | 0.230 |
1 | 4545 | 0.220 |
1 | 25000 | 0.215 |
3 | 14448 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 145820 | 2 |
0.295 | 3390 | 1 |
0.310 | 45789 | 1 |
0.330 | 180900 | 3 |
0.350 | 79920 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Is oil undervalued?
NXS (ASX) Chart |